Generation Bio Co. (GBIO)
US Market

Generation Bio (GBIO) Stock Price & Analysis


GBIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.15 - $7.35
Previous Close$3.78
Average Volume (3M)131.51K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$314.14M
Total Debt (Recent Filing)$80.63M
Price to Earnings (P/E)-1.8
Nov 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.08
Shares Outstanding65,928,503
10 Day Avg. Volume108,033
30 Day Avg. Volume131,515
Standard Deviation0.30
Financial Highlights & Ratios
Price to Book (P/B)1.02
Price to Sales (P/S)283.19
Price to Cash Flow (P/CF)2.60
P/FCF Ratio2.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside111.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Generation Bio Co.’s price range in the past 12 months?
Generation Bio Co. lowest stock price was $3.15 and its highest was $7.35 in the past 12 months.
    What is Generation Bio Co.’s market cap?
    Currently, no data Available
    When is Generation Bio Co.’s upcoming earnings report date?
    Generation Bio Co.’s upcoming earnings report date is Nov 14, 2023 which is in 51 days.
      How were Generation Bio Co.’s earnings last quarter?
      Generation Bio Co. released its earnings results on Aug 02, 2023. The company reported -$0.47 earnings per share for the quarter, beating the consensus estimate of -$0.483 by $0.013.
        Is Generation Bio Co. overvalued?
        According to Wall Street analysts Generation Bio Co.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Generation Bio Co. pay dividends?
          Generation Bio Co. does not currently pay dividends.
          What is Generation Bio Co.’s EPS estimate?
          Generation Bio Co.’s EPS estimate is -$0.48.
            How many shares outstanding does Generation Bio Co. have?
            Generation Bio Co. has 65,928,505 shares outstanding.
              What happened to Generation Bio Co.’s price movement after its last earnings report?
              Generation Bio Co. reported an EPS of -$0.47 in its last earnings report, beating expectations of -$0.483. Following the earnings report the stock price went up 0.223%.
                Which hedge fund is a major shareholder of Generation Bio Co.?
                Among the largest hedge funds holding Generation Bio Co.’s share is Farallon Capital Management, L.L.C.. It holds Generation Bio Co.’s shares valued at N/A.


                  Generation Bio Stock Smart Score

                  The Generation Bio stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Generation Bio Co.

                  Generation Bio Co is a genetics medicine company which is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.


                  Top 5 ETFs holding GBIO

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Fidelity Blue Chip Growth ETF
                  Up to five ETFs with an Outperform Smart Score that hold GBIO. The ETFs are listed according to market value of GBIO within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Allogene Therapeutics
                  Dianthus Therapeutics
                  Arvinas Holding Company

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis